Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NCBR Investment Fund ASI S.A. is a co-investment venture capital fund based in Warsaw, Poland, operating under the National Centre for Research and Development. The fund has a total size of €150 million and focuses on small and medium-sized enterprises (SMEs) in growth or expansion phases. It supports companies with transaction values ranging from 3 million PLN to 15 million EUR.
This fund targets SMEs transitioning from seed and startup stages to growth, particularly those commercializing research and development projects. Investments range from $800K to $16M, with a focus on biotech, SaaS, and food-agtech sectors. Eligible companies must be micro, small, or medium enterprises based in Poland or other OECD countries and operational for no longer than seven years since their first commercial sale.
Notable portfolio companies include IMAGENE.ME, a biotechnology firm specializing in personal genomics; Digital First AI, which offers AI-driven SaaS solutions for marketing; HiProMine, an alternative protein producer utilizing insect farming technology; and Saventic Health, known for its innovative medical diagnostics algorithm.
Email your pitch deck to biuro@nifasi.pl for consideration.
Yes, NCBR Investment Fund ASI S.A. often leads investment rounds, particularly in the growth equity stage.
The fund is open to follow-on investments, especially for companies demonstrating significant growth and potential.
The current fund size is €150 million, aimed at supporting SMEs in various sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.